Tracey O’Brien: Great to attend day 1 of the The Australian Precision Oncology Symposium
Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, shared a post on LinkedIn:
“Great to attend day 1 of the The Australian Precision Oncology Symposium (APOS) and enjoy inspiring conversation with so many at the conference dinner. Congratulations to David Thomas, Ian Black, Mandy Ballinger and the entire Omico team for pulling together a stellar line up of international and national speakers.
It was standing room only with some of the brightest minds in science, clinical oncology and industry coming together to share knowledge, build collaboration and challenge each other to push boundaries even further in a united passion to drive better diagnostics and therapeutics for all cancer patients, particularly those with hard to treat, relapsed or rare cancers.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023